118 related articles for article (PubMed ID: 1754859)
1. Ranitidine for non-ulcer dyspepsia. A clinical study of the symptomatic effect of ranitidine and a classification and characterization of the responders to treatment.
Farup PG; Larsen S; Ulshagen K; Osnes M
Scand J Gastroenterol; 1991 Nov; 26(11):1209-16. PubMed ID: 1754859
[TBL] [Abstract][Full Text] [Related]
2. Ranitidine effectively relieves symptoms in a subset of patients with functional dyspepsia.
Farup PG; Wetterhus S; Osnes M; Ulshagen K
Scand J Gastroenterol; 1997 Aug; 32(8):755-9. PubMed ID: 9282965
[TBL] [Abstract][Full Text] [Related]
3. Are frequent short gastro-oesophageal reflux episodes the cause of symptoms in patients with non-ulcer dyspepsia responding to treatment with ranitidine?
Farup PG; Hovde O; Breder O
Scand J Gastroenterol; 1995 Sep; 30(9):829-32. PubMed ID: 8578179
[TBL] [Abstract][Full Text] [Related]
4. Ranitidine in the treatment of non-ulcer dyspepsia. A placebo-controlled study in the Federal Republic of Germany.
Müller P; Hotz J; Franz E; Simon B
Arzneimittelforschung; 1994 Oct; 44(10):1130-2. PubMed ID: 7818586
[TBL] [Abstract][Full Text] [Related]
5. The multi-crossover model for classifying patients as responders to a given treatment.
Larsen S; Farup P; Flaten O; Osnes M
Scand J Gastroenterol; 1991 Jul; 26(7):763-70. PubMed ID: 1896820
[TBL] [Abstract][Full Text] [Related]
6. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
Carvalhinhos A; Fidalgo P; Freire A; Matos L
Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
[TBL] [Abstract][Full Text] [Related]
7. [Ranitidine therapeutically effective in functional dyspepsia with reflux-like symptoms].
Jebbink HJ; Smout AJ; van Berge Henegouwen GP
Ned Tijdschr Geneeskd; 1993 Aug; 137(35):1772-5. PubMed ID: 8371822
[TBL] [Abstract][Full Text] [Related]
8. Dyspepsia: incidence of a non-ulcer disease in a controlled trial of ranitidine in general practice.
Saunders JH; Oliver RJ; Higson DL
Br Med J (Clin Res Ed); 1986 Mar; 292(6521):665-8. PubMed ID: 3081221
[TBL] [Abstract][Full Text] [Related]
9. The symptomatic effect of 1-day treatment periods with cimetidine in dyspepsia. Combined results from randomized, controlled, single-subject trials.
Johannessen T; Kristensen P; Petersen H; Fosstvedt D; Løge I; Kleveland PM; Dybdahl J
Scand J Gastroenterol; 1991 Sep; 26(9):974-80. PubMed ID: 1947791
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.
Veldhuyzen van Zanten SJ; Chiba N; Armstrong D; Barkun A; Thomson A; Smyth S; Escobedo S; Lee J; Sinclair P
Am J Gastroenterol; 2005 Jul; 100(7):1477-88. PubMed ID: 15984968
[TBL] [Abstract][Full Text] [Related]
11. Sucralfate versus ranitidine in non-ulcer dyspepsia: results of a prospective, randomized, open, controlled trial.
Misra SP; Dwivedi M; Misra V; Agarwal SK
Indian J Gastroenterol; 1992 Jan; 11(1):7-8. PubMed ID: 1551720
[TBL] [Abstract][Full Text] [Related]
12. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
Champion MC; MacCannell KL; Thomson AB; Tanton R; Eberhard S; Sullivan SN; Archambault A
Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia; a randomized, double-blind placebo-controlled crossover study.
Holtmann G; Kutscher SU; Haag S; Langkafel M; Heuft G; Neufang-Hueber J; Goebell H; Senf W; Talley NJ
Dig Dis Sci; 2004 Apr; 49(4):672-9. PubMed ID: 15185877
[TBL] [Abstract][Full Text] [Related]
14. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
15. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group.
Blum AL; Arnold R; Stolte M; Fischer M; Koelz HR
Gut; 2000 Oct; 47(4):473-80. PubMed ID: 10986206
[TBL] [Abstract][Full Text] [Related]
16. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
[TBL] [Abstract][Full Text] [Related]
17. [The effectiveness of ranitidine in non-ulcer dyspepsia (functional dyspepsia) in comparison with an antacid].
Hotz J; Plein K; Bunke R
Med Klin (Munich); 1994 Feb; 89(2):73-80, 107. PubMed ID: 8164599
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled study of the efficacy and safety of non-prescription ranitidine 75 mg in the prevention of meal-induced heartburn.
Pappa KA; Williams BO; Payne JE; Buaron KS; Mussari KL; Ciociola AA
Aliment Pharmacol Ther; 1999 Apr; 13(4):467-73. PubMed ID: 10215730
[TBL] [Abstract][Full Text] [Related]
19. Non-ulcer dyspepsia in Nigerians clinical and therapeutic results.
Olubuyide IO; Ayoola EA; Okubanjo AO; Atoba MA
Scand J Gastroenterol Suppl; 1986; 124():83-7. PubMed ID: 3334188
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of sucralfate in treatment of non-ulcer dyspepsia. A double-blind placebo-controlled study.
Gudjónsson H; Oddsson E; Björnsson S; Gunnlaugsson O; Theodors A; Jónasson TA; Bonnevie O; Thjodleifsson B
Scand J Gastroenterol; 1993 Nov; 28(11):969-72. PubMed ID: 8284632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
